AMS Analytix is a Healthcare Data Analytics and Insights Company that offers a wide range of quantitative and qualitative data and research solutions to pharmaceutical companies in the Middle East and North Africa.
Empowerment
Realized
Your Competitive Advantage in Challenging Markets
Enabling Data-Driven Decisions
Enabling Data- Driven Decisions
Market data stands as a cornerstone for success in the highly competitive pharmaceutical landscape, particularly in under-regulated markets where chaos and uncertainty may prevail and where opportunities are abundant. By leveraging data-driven insights, pharmaceutical companies can navigate the complexities of these markets, optimize their operations, create value for stakeholders, and identify untapped potential.
AMS’s current strong presence in Jordan, Iraq, Syria, Sudan, and Libya positions it as a valuable partner for pharmaceutical companies operating in these markets. With a deep understanding of the unique challenges and opportunities in each region, AMS offers tailored advice and support to help clients achieve their business goals.
AMS Core
At the heart of AMS’s operations lies the production of syndicated pharmaceutical sales monitors for various MENA markets. These comprehensive reports provide accurate and up-to-date information on the sales of pharmaceutical products in the private sector, encompassing a wide range of therapeutic categories, spanning from antibiotics and analgesics to cardiovascular drugs and oncology treatments. These reports are meticulously compiled using data gathered from a multitude of sources enabling businesses to track their performance, identify growth opportunities, and develop effective marketing strategies.
Quality Services
AMS quarterly sales monitors cover the pharmaceutical markets in Jordan, Iraq, Syria, Sudan and most recently in Libya. These studies are designed to accurately reflect the quantitative sales of pharmaceutical products in the private sector. Each study undergoes rigorous internal audits to ensure that the highest standards of quality are maintained.
At AMS, we believe that understanding the unique research requirements of each client is key to the successful design and execution of a market research project. This customized approach is essential for maximizing the outcome of the conducted research and delivering actionable insights that align with your objectives
Being a leading provider of market data, research and consulting services to the pharmaceutical industry, AMS has laid the foundations to the expansion of its services to include patient support and affordability programs in Jordan and Iraq. This expansion marks a significant milestone in AMS's commitment to providing comprehensive solutions that address the unique challenges faced by pharmaceutical companies operating in the MENA region.
With over 2 million prescriptions annually in Jordan, this quarterly study has proved to be an indispensable tool for pharmaceutical companies seeking to evaluate the effectiveness of their sales representatives and gain a competitive edge. By analyzing data from a representative sample of prescriptions, AMS provides in-depth insights into prescribing patterns, brand performance, and market dynamics. This study will be available soon in the Iraqi Market.
Leveraging its team's extensive experience in the pharmaceutical industry, a strong presence in several MENA countries, and an in-depth understanding of local culture and market dynamics, AMS is uniquely positioned to provide comprehensive consultations to pharmaceutical companies operating in the region. Whether your company seeks a market entry strategy, a distribution partner, or a comprehensive market analysis study, AMS is your ideal partner.
Complementing its quarterly sales monitors for the private market, AMS also delves into the realm of public procurement by issuing quarterly studies on institutional (tender) purchases. This comprehensive approach provides businesses with an unparalleled holistic view of both the private and the public data which provides an accurate analysis and presentation of all tenders awarded by and delivered to the Iraqi MOH (KIMADIA).
QUALITY SERVICE
Medical Prescriptions Monitors
With over 2 million prescriptions annually in Jordan, the Medical Prescription Monitor has proved to be an indispensable tool for pharmaceutical companies seeking to evaluate the effectiveness of their sales representatives and gain a competitive edge. This quarterly study goes beyond mere sales figures, offering a qualitative assessment of the promotional messages reaching physicians.
Pharma Consultations
Leveraging its team's extensive experience in the pharmaceutical industry, a strong presence in several MENA countries, and an in-depth understanding of local culture and market dynamics, AMS is uniquely positioned to provide comprehensive consultations to pharmaceutical companies operating in the region. Whether your company seeks a market entry strategy, a distribution partner, or a comprehensive market analysis study, AMS is your ideal partner.
Custom Market Research
At AMS, we believe that understanding the unique research requirements of each client is key to the successful design and execution of a market research project. This customized approach is essential for maximizing the outcome of the conducted research and delivering actionable insights that align with your objectives.
Institutional (Tender) Studies
Complementing its sales monitors for the private market, AMS also delves into the realm of public procurement by issuing quarterly studies on institutional (tender) purchases. This comprehensive approach provides businesses with an unparalleled holistic view of both the private and the public data which provides an accurate analysis and presentation of all tenders awarded by and delivered to the Iraqi MOH (KIMADIA).
AMS Sales Monitors
AMS quarterly sales monitors cover the pharmaceutical markets in Jordan, Iraq, Syria, Sudan and most recently in Libya. These studies are designed to accurately reflect the quantitative sales of pharmaceutical products in the private sector. Each study undergoes rigorous internal audits to ensure that the highest standards of quality are maintained.
Patient Support Programs
Being a leading provider of market data, research and consulting services to the pharmaceutical industry, AMS has laid the foundations to the expansion of its services to include patient support and affordability programs in Jordan and Iraq. This expansion marks a significant milestone in AMS's commitment to providing comprehensive solutions that address the unique challenges faced by pharmaceutical companies operating in the MENA region.
Our ClientsTestimonials
-
“Despite the challenging market conditions in Iraq, AMS produced high quality Pharma Audit reports. AMS team paid attention to details and applied rigorous processes to ensure accuracy and completeness of data produced"
Mazen Abu Samha MSD MANAGING DIRECTOR- IRAQ AND YEMEN -
“We had subscribed AMS - Iraq Sales Monitor, we found it clear and profound market data source. Especially their Pharma market insights and one-to-one service extended have been very useful and look forward for such services in future. We would definitely recommend AMS.”
Arun Baviskar Manager-International MarketingRead more -
“Our experience working with AMS over the years has been very positive. AMS understands our requirements and the quality of the data they provide us in the challenging Iraqi market, where they operate, is second to none.”
Hany Mounir Marketing Director General MedicineNear East, Merck Serono Middle East FZ-LLCRead more
Discover More
Market data in the Pharmaceutical Industry is arguably the most vital ingredient to plan and execute
activities; especially in an industry where prices and advertising are heavily regulated.
Data is not only important for strategic planning i.e. new launches but also for tactical execution measures i.e. growing market share, deciding on seasonal offers etc.
Data helps businesses monitor their sales performance, improve their sales force efficiency, create value
for prescribers, dispensers and patients and achieve challenging targets.